Variant · Snv
SPEF2 NM_024867.4(SPEF2):c.2399-181A>G
CI-VAR-00201163Explore in graph →NM_024867.4:c.2399-181A>GClinVar 1291797 rs11957765
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1291797 | Benign | criteria provided, single submitter | 1 | Malignant lymphoma, large B-cell, diffuse; Lymphoma; Nonpapillary renal cell carcinoma; Ovarian serous cystadenocarcinoma; Thymoma; Cholangiocarcinoma; Acute myeloid leukemia; Familial pancreatic carcinoma; Gastric cancer | germline | 2 | May 16, 2021 | clinvar |